Enliven Therapeutics

ELVN · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 25 days ago

Previous year: -$0.08

Total Operating Expenses

Previous year: $75.5M

Previous year: $83.3M

+226.4%

Loading...

Enliven Therapeutics

Unlock previous datapoints

Upgrade

Enliven Therapeutics

Unlock previous datapoints

Upgrade

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$2.35B

P/E Ratio

-21.24

Sector

N/A

Industry

N/A

52-Week High

$39.3

52-Week Low

$14.9

R&D Expenses

$17.9M

G&A Expenses

$4.82M

Total Operating Expenses

$22.7M

Other Income, Net

$3.36M

Weighted Avg Shares

41.13K

Products

Get in Touch

Resources

Enliven Therapeutics

Enliven Therapeutics

Enliven Therapeutics

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics